Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | TYMP | P19971 | 1/20 | 0.32 |
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | AHR | P35869 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15133542 | 0.80 | AHR (0.36) | SLC2A1MAPTAHRKMT2AKDM4E | |
| SCHEMBL159239 | 0.76 | — | — | |
| SCHEMBL12891616 | 0.76 | AHR (0.33) | SLC2A1MAPTAHRKMT2AKDM4E | |
| SCHEMBL21564020 | 0.76 | MAPT (0.35) | SLC2A1MAPTAHRKMT2AKDM4E | |
| SCHEMBL9998974 | 0.76 | — | — | |
| Hydrochloric Acid SCHEMBL6216888 | 0.71 | — | — | |
| SCHEMBL11503649 | 0.69 | MAPT (0.31) | MAPT | |
| SCHEMBL10021065 | 0.67 | PDE3B (0.45) | MAPTTYMPCYP1A2CYP2C9CYP2C19 | |
| Clopidol SCHEMBL11480048 | 0.67 | SLC2A1 (0.43) | SLC2A1MAPTKMT2AKDM4EALDH1A1 | |
| SCHEMBL4560425 | 0.65 | TYMP (0.56) | TYMPATAD2KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010094738-A1 | PHOSPHATE ESTER OF A 4-PYRIDONE DERIVATIVE AND ITS USE IN THE CHEMOTHERAPY OF PARASITIC INFECTIONS | GLAXO GROUP LIMITED (GB) | 2010-08-26 | — | — | WO | disclosed |
| US-7597868-B2 | Processes for singlet oxygen generation and fullerene oxidation | KEIO UNIVERSITY (JP) | 2009-10-06 | — | — | US | disclosed |
| US-20070286791-A1 | Processes for singlet oxygen generation and fullerene oxidation | KEIO UNIVERSITY (JP) | 2007-12-13 | — | — | US | disclosed |